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ABSTRACT 
Avian infectious bronchitis virus (AIBV), a 
coronavirus, causes acute respiratory disease in chickens. 
A rapid diagnostic method was developed for the 
detection of AIBV in infected chickens using a modified 
indirect double antibody sandwich (MIDAS) enzyme-linked 
immunosorbent assay (ELISA). The system was compared 
with isolation of virus by the conventional use of chicken 
embryos. 
The MIDAS ELISA was as sensitive as isolation of 
virus with the use of chicken embryos. However, the MIDAS 
ELISA was more rapid and easier to apply than the use of 
chicken embyos. 
In detecting antibody against 
indirect (MI) ELISA was also developed. 
AIBV, a modified 
The MI ELISA was 
used to study the immune response of experimentally infected 
chickens. Results indicated that antibody was not detected 
in chickens prior to infection, however, the antibody 
increased in titer as the infection progressed. With 
increased antibody levels in chickens, shedding of the virus 
in the trachea and the intestines gradually decreased and 
disappeared, except in two of eleven chickens whereby 
ii 
virus shedding persisted in the intestines for as long as 
twenty-eight days and in the presence of humeral antibodies. 
iii 
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PREFACE 
All my work and effort is dedicated in loving memory 
of my Grandmother Fannie and my Grandfather Samuel; two 
wonderful people who helped to shape my life and character. 
They instilled in me the all important attitude • • "never 
say can't, because you can do whatever you want to do, 
you can!" 
They even left me with a comforting thought which I 
wish to share, it was a poem written by Clare Harner Lyon: 
Do not stand at my grave and weep; 
I am not there. I do not sleep; 
I am a thousand winds that blow. 
I am the diamond glints on snow. 
I am the sunlight on ripened grain. 
I am the gentle autumn's rain. 
When you awaken in the morning's hush, 
I am the swift uplifting rush 
Of quiet birds in circled flight. 
I am the soft stars that shine at night. 
Do not stand at my grave and cry: 
"I am not there. I did not die." 
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LITERATURE REVIEW 
I. Introduction. 
Avian infectious bronchitis virus (AIBV) causes a 
disease which has emerged within the last four decades from 
the melange of the "respiratory disease complex" of poultry 
to a well-defined and separate entity (1). 
In April of 1930, Schalk and Hawn (2) were the 
first to describe and report "an apparently new respiratory 
disease of baby chicks" in North Dakota and throughout the 
North Central region of the United States. In 1936, Beach 
and Schalm (3) established that the etiologic agent was a 
filterable virus. Beaudette and Hudson (4) were the first 
to cultivate the virus in embryonated chicken eggs. With 
the establishment of avian infectious bronchitis as a 
distinct disease, a considerable body of information on the 
morphological and biological properties followed due to 
rapidly developing technology and research techniques. 
Avian infectious bronchitis (AIB) is an acute, 
highly contagious, viral respiratory disease of chickens 
characterized by respiratory distress, tracheal rales, 
coughing associated with the accumulation of excess mucus in 
the bronchi, and sneezing. In young chicks, there may be a 
1 
2 
nasal discharge, and in laying flocks there may be a 
precipitous drop in egg production. 
Avian infectious bronchitis virus (AIBV) is of great 
economic importance to the poultry industry. In young 
chicks there may be high morbidity, and in some instances, 
mortality, and a debilitating effect which results in 
decreased weight gain and feed efficiency. In laying flocks 
the major loss is decreased production and poor quality of 
eggs 
of 
due to ovarian damage caused by the disease. 
its highly transmissible nature and world 
Because 
wide 
prevalence, AIB is a constant threat to unvaccinated 
flocks. 
producer. 
Immunization programs are costly to the poultry 
Plus, the stress from natural infection or from 
vaccination may be a predisposing factor to other infectious 
outbreaks. 
Presently, AIBV is not known to be of public health 
significance, although "bronchitis-like" agents have been 
isolated from human respiratory disease such as the common 
cold (5,6,7) and low neutralizing antibodies titers have 
been detected in blood from people associated with poultry 
( 8 ) • 
Cunningham (1) and Hofstad (7) have published review 
articles on AIBV. 
II. Etiology. 
A. Classification. 
AIBV is considered to be a species of the genus 
3 
coronavirus of the family Coronaviridae (9, 1 0 , 1 1 ) • This 
group of avian, human, and murine viruses have AIBV as the 
prototype (12). The name "coronavirus" was selected because 
of the characteristic resemblance of the viruses to the 
solar corona. 
B. Morphology. 
The virus particles tend to be generally spherical, 
but also pleomorphic with characteristic club-shaped 
projections uniformly distributed on its surface. The size 
of the particles range from 60-160 nm in diameter (9,12,13, 
14). The surface projections are 20 nm long with a 10 nm 
wide bulbous dilation of the distal end (12). The bouyant 
density of the virus from allantoi~ fluid of embryonated 
eggs ranges from 1.12-1.22 g/ml (9,15) with a major peak at 
density 1.17-1.18 g/ml (16) in sucrose. The sedimentation 
constant is 344 S (17). 
C. Viral composition. 
The nucleic acid of AIBV is ribonucleic acid (RNA). 
The genome is the largest viral RNA known to date. It is 
single-stranded, polyadenylated, nonsegmented RNA which is 
of positive polarity and is therefore infectious (18,19,20). 
The estimated 
6 
about 3 X 10 
AIBV 
specific RNA. 
molecular weight of the genome 
6 
to 9.0 X 10 (19,20,21). 
ranges from 
synthesizes six discrete species of virus-
These comprise the genome and five single-
4 
6 
stranded RNAs ranging in molecular weight from 0.8 X 10 to 
6 
2 .6 x 10 • All of the smaller RNAs are subgenomic and are 
probably viral mRNA's with specific functions (20). 
The polypeptide composition of AIBV has been 
reported to contain as few as three and as many as sixteen 
structural proteins in the virion (16,22,23,24,25). 
The susceptibility to ether indicates an essential 
lipid (14) in the envelope of the virus. 
The cellular receptors of AIBV are complex and 
contain thiol (SH) groups and N-acetylneuraminic acid (NANA) 
as an integral part of the receptor sites (26). The 
neuraminidase-like activity is associated with the 
hemagglutinin of AIBV (27). 
D. Antigens. 
There are at least three antigenically distinct 
soluble virus-specific AIBV antigens in viral allantoic 
fluid. The viral antigens are smaller in size than the 
virus particle. Antigen 1 is the smallest and seems to be 
made up entirely of protein. Antigen 3 is the largest and 
like antigen 1 is distributed over the surface of the virus 
particle. Antigen 2 is a ribonucleoprotein that residues in 
the virion (28). 
E. Resistance to physical and chemical agents. 
Most strains of AIBV in allantoic fluid are 
inactivated at 56 ° c in 15 min, but some strains can survive 
for a longer period of time (29). AIBV stores well at low 
5 
temperatures as infected allantoic fluid (1,7) and can be 
stored indefinitely if lyophilized. 
The optimal pH 7.8 gives the virus maximum 
stability. 
F. Replication. 
The site of multiplication is in the cytoplasm. 
AIBV enters the cells of chicken chorioallantoic membrane by 
viropexis. Virus uptake is triggered by attachment of the 
virus to the cell membrane (30). Maturation occurs in the 
cytoplasm and mature virions bud through the endoplasmic 
reticulum. No budding at the plasma membrane has been 
observed. Replication of the virus requires a funtionally 
competent cell nucleus and cellular ~olymerase II (31). 
G. Strains. 
Prior to 1956 AIBV was considered to be caused by a 
single antigenic type. However, since that time a number of 
isolates have been shown to be antigenically different. 
Using neutralization and chicken immunity tests, the 
following serotypes of AIBV have resulted: Massachusetts 
(M-41), Connecticut (M-46), Iowa 97, Iowa 609, Gray, Holt, 
JMK, RPL, New Hampshire EF, Clark 333, SE 17, Florida, 
Arkansas 99, Delaware 2868, Delaware 2897, Wachtel, I 1731, 
Indiana, Maine 209, Holland 52, Italian, Cuxhaven, and 
Australian "T" strain (17,32,33,34,35,36,37,38,39,40,41) 
are a few. The Beaudette (M-42) strain is antigenically 
related to M-41 and it has been used extensively as the 
6 
reference virus for neutralization tests. There is still a 
great need for a systematic approach to the classification 
of AIBV in order to study the antigenic and the 
immunological differences among the many subtypes. 
H. Laboratory host systems. 
AIBV grows in 9-, 10-, and 11-day-old embryonated 
chicken eggs. The characteristic embryo changes are seen 
several days postinoculation (PI). During candling the 
embryo may appear sluggish and weak. Upon opening the egg 
the embryo is seen "curled" in a spherical ball with a wry 
neck and deformed feet compressed over the head. A 
thickened amnion is closely adherent to the embryo. The 
yolk sac appears shrunken and an inc r. eased volume of usually 
clear allantoic fluid is present. A consistent internal 
lesion of the bronchitis-infected embryo is the persistence 
of urates in the mesonephron. 
When the virus is injected into the chorioallantoic 
sac (CAS), the highest concentration of virus is recovered 
from the chorioallantoic membrane (CAM), followed by the 
allantoic fluid, amniotic fluid, and liver. Maximum titer 
of virus was detected in eggs incubated at 37° C for 30 hours 
(42). 
The virus can also be grown in primary chicken 
embryo kidney cells (43). 
I. Interference and Synergism. 
Interference with the production of Newcastle 
7 
disease (NOV) by AIBV has been demonstrated to occur in 
chickens, chicken embryos, and chicken kidney cells ( 1). 
Avian encephalomyelitis (AE) virus interferes with AIBV in 
chicken embryos (44). The mechanism of interference has not 
been clearly defined. 
Coexistence, but not synergism has been reported 
for AIBV and laryngotrachitis (!LT). Synergism exists 
between AIBV and ~plasma gallisep~~~ and B~mophilus 
gallinar.iYm in chickens (1). 
J. Persistence. 
Studies assessing the duration of AIBV infections 
in chickens produced conflicting results. Fabricant and 
Levine reported the successful isolation of virus from eggs 
and from tracheal swabs for forty three days and four weeks 
respectively (45). Other reports showed that virus could be 
recovered from hens and eggs at six but not seven weeks 
after infection (46). Virus was also shown to be recovered 
form lungs up to 21 days; from anterior nares, trachea, 
from the kidney, bursa, spleen, and blood up to 14 days; 
liver and brain up to 5 days; and from the caecal tonsils 
for 14 weeks (46,47). 
AIBV may enter organs of the respiratory system 
directly from outside the body and be distributed to various 
organs due to the development of viremia. The same virus 
once invading the blood stream, can find its way back to the 
respiratory organs with ease (47). On the other hand, virus 
8 
was also demonstrated in the contents of the large and small 
intestines in great quantity for a relatively long period of 
time and this fact may be important when discussing 
persistence of AIBV. 
III. Pathogenesis and epizootiology. 
The chicken is the only natural host for AIBV. All 
ages, sexes, and breeds are susceptible. 
A. Transmission. 
The virus in secretions from the respiratory tract 
of infected chickens spreads rapidly throughout a flock 
under natural conditions. Chickens develop respiratory signs 
within 36 hours or more. Airborne transmission is 
considered to be the natural route ~f infection, 
the optimal 
although, it 
environmental conditions are not 
has been assumed during epizootics, 
however, 
known, 
that the 
virus spreads between flocks where the farms are close in 
proximity and in the direction of the prevailing winds. 
Contaminated feed, water, clothing, and equipment, 
as well as, the movement of personnel from flock to flock 
may serve for indirect transmission of the virus. 
B. Carriers and vectors. 
Vectors do not appear to be a factor in the 
transmission of AIBV. 
Recurrence of AIBV in certain areas or on the same 
Premise year after year indicates that recovered chickens 
may serve as "carriers" of the virus as an inapparent 
9 
infection or that there is a continued cross infection 
rather than a true carrier state (1). 
c. Incubation period. 
The incubation period of infectious bronchitis is 
18-36 hours, depending upon the dosage and route of 
inoculation (7). 
D. Clinical features. 
a. Chicks. 
In chicks less than five weeks old, characteristic 
respiratory signs are gasping, coughing, and tracheal rales, 
and a nasal discharge. Excessive lachrymation may be 
observed and occasionally chicks may have swollen sinuses. 
The chicks appear depressed and many are seen huddled under 
the heat source. 
The morbidity rate is high, 
may be as high as 25% or more (1). 
and the mortality rate 
Feed consumption and 
weight gain is markedly reduced. If chicks are infected 
under two weeks of age permanent damage to the ovary and 
oviduct may occur. 
b. Growing chickens. 
In chicks over five weeks of age there are tracheal 
rales with some gasping and coughing. The disease may go 
unnoticed if the birds are not carefully observed. Hales 
are usually not heard unless the chickens are handled or the 
caretaker listens to the flock at night when the birds are 
quiet. 
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c. Adult laying flocks. 
In adult laying flocks the signs are the same as 
for the growing birds. In addition the flock usually 
experiences a drop in egg production. Flocks affected in 
the latter part of their laying year usually have a marked 
drop in egg production and a molt. These flocks require 
long periods of time to recover production and usually 
become unprofitable. Pullets in good condition may suffer 
only a slight drop in production and regain normal 
production within a few weeks after recovery from 
respiratory signs. 
The reduction in egg production, increase in the 
number Of unset table hatching . eggs, and reduced 
hatchability of those eggs set is reflected in the small, 
soft-shelled, malformed, and abnormal quality of the first 
eggs when a flock starts to return to production (1). Shell 
irregularities in recovered flocks may persist for an 
indefinite period of time. 
The morbidity rate may be high in the growing stock 
and adult birds, but, the mortality rate is usually low. 
E. Gross lesions. 
Commonly encountered gross lesions at necropsy of 
affected birds reveals a serous, catarrhal, or caseous 
exudate in the trachea, nasal passages, and sinues. There 
is also congestion and edema of the lungs, fibrinous 
inflammation or cloudiness of the air sac membranes with 
1 1 
possible yellow, caseous exudate. Yellow, caseous plugs 
may be in the lower trachea and bronchi of chicks that die. 
catarrhal inflammation of the nasal passages and sinuses is 
seldom encounted in chickens over two months of age. Small 
areas of pneumonia may also be observed around the large 
bronchi (1,7). 
F. Immunity. 
a. Active. 
Active immunity results from the recovery of 
chickens from natural or artifical infection with AIBV as 
soon as the symptoms have subsided. The primary antigenic 
stimulus is accompanied by a marked, but transient increase 
of total globulin and gamma globul~n (48). It requires 
about three weeks for chickens to reach a high level of 
antibody following exposure to AIBV. Flocks that have 
experienced an outbreak of bronchitis have some degree of 
immunity, and antibodies can be demonstrated for at least a 
year. However, the antibodies may decline sufficiently for 
reinfection to occur, especially with an overwhelming 
challenge dose of virus or experience with severe natural 
condition. The pl~rality of the serotypes complicates 
clinical interpretation of the immune status, particularly 
with reinfection, as cross immunity is not always effective 
for subsequent infections (7). 
Local tracheal immunity has an important role in 
resistance to bronchitis. Chickens recovered from aerosol 
12 
infection with a high embryo passage virus may be resistant 
for relatively short periods of time to subsequent challenge 
with low embryo passage virus even though the neutralizing 
antibody level is low or not demonstrable (49). This may 
have something to do with an IgA-like immunoglobulin (50,51, 
52,53,54) found in chickens. 
Cell mediated immunity (CMI) is also part of the 
immunological response of chickens to both primary and 
secondary vaccination. However, there is no direct 
correlation shown between CMI reponses and antibody titers 
or between degrees of CMI responses to vaccination and 
challenge and clinical signs after challenge (55). 
b. Passive. 
Naturally acquired passive immunity results from 
maternal antibodies in the yolk of eggs laid by hens 
recovered from natural or artifical infection. Antibodies 
are demonstrable in the blood of embryos after about 15 days 
of incubation (56). The antibody levels in the chick is 
highest soon after hatching, 
negligible level by four weeks, 
declines steadily to a 
and the chick is then 
susceptible to the virus (57,58,59). Passive immunity 
serves to reduce the severity of the disease but not to 
Prevent respiratory infection following exposure to the 
virus. 
IV. Diagnosis. 
Diagnosis of AIBV must be based on the isolation of 
13 
the virus or by serological tests. 
Similarities in the early stages of the infection 
with other disease states such as NDV, !LT, infectious 
coryza, chronic fowl cholera, fowl pox, vitamin A deficency, 
and chronic respiratory disease (60), make it difficult to 
make a field diagnosis of AIBV. 
After the disease has progressed sufficently, 
the neurologic disturbances associated with NDV, the forced 
,expiration associated with !LT, and the swollen face and 
nasal discharge associated with infectious coryza, allow a 
presumptive diagnosis to be made on the basis of clinical 
signs, morbidity, and mortality. 
A. Virus isolatipn. 
Isolation of AIBV is accomplished by inoculating 9-
to 11-day-old embryonated chicken eggs via the CAS with a 
suspension of lung, bronchii, and trachea from infected 
chickens in the acute stage of the disease (1). Penicillin 
and streptomycin are usually used to control bacterial 
contamination. Identity of the virus is based on gross 
pathologic alteration. It is often necessary to make two or 
three passages of the virus before typical alterations are 
produced. The allantoic-amniotic fluid (AAF) should be 
collected after three days PI for further passage. The 
remaining embryonated eggs should be examined six or seven 
days PI (61). 
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B. Serology 
The diagnosis of AIBV by serologic methods is based 
on demonstation of antigen or antibody. Each test has its 
own advantages and disadvantages. 
a. Virus Neutralization. 
Virus neutralization (VN) is a test which usually 
employs either the variable virus-constant serum or the 
constant virus-variable serum procedure (62). 
The first sample of blood is collected during the 
initial stages of the disease and the second sample is taken 
in two or three weeks. Both samples of serum are tested for 
neutralizing antibodies in embryonated eggs. 
VN is the most widely used serologic test for 
identification, 
AIBV (63,64). 
screening and classifying field isolates of 
Although this method is effective, it is 
laborious to set up; expensive and time consuming. 
b. Plaque Reduction. 
The reduction of plaques in a primary chicken 
embryo kidney cell (CEKC) culture for the detection of AIBV-
neutralizing antibodies has been reported to be a practical 
test (65). This test is comparable to classical methods of 
VN which use the embryonated egg for the assay system. 
c. Agar Gel Precipitation. 
Agar gel precipitation (AGP) ia another serologic 
test which is particularly useful for the rapid, routine 
differential identification of viruses (66). The material 
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necessary for the AGP test is inexpensive. The test can be 
set up and read more quickly than the VN or VI procedures. 
The AGP test is well adapted for processing large numbers of 
serum samples. Precipitins appear sooner than significant 
levels of serum neutralizing antibodies in the majority of 
birds. Diagnosis can be made in five to eleven days and the 
test is most efficent during the period after infection when 
the VI efficiency is decreasing and VN titers are not yet 
uniformly positive. 
The AGP test does have its disadvantages. The test 
is subject to errors in reading and interpretation. The 
bronchitis precipitins are detectable for only a relatively 
short period of time. Plus, the test is not suitable for 
individual bird diagnosis, since precipitins are 
produced in every susceptible bird exposed to AIBV. 
d. Immunofluorescence. 
not 
The immunofluorescence (IF) procedure has been 
employed with considerable success for the identification, 
differentiation, and study of AIBV in infected cell 
cultures ( 67). The use of divalent or polyvalent antisera 
and either frozen sections or impression smears of the 
tracheal explants may be advantageous for routine diagnosis 
Of AIBV. Cross fluorescence between serotypes is considered 
to correspond more closely to cross-protection tests in 
chickens than to cross-neutralizaiton test by PR in CEKC. 
The biggest disadvantage with IF is that AIBV does 
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not grow in cell culture upon initial isolation but requires 
primary embryo adaption. 
fixation 
CF test 
e. Compliment-fixation. 
Direct, indirect, and modified direct compliment-
(CF) tests have been applied to AIBV (1,68). The 
is useful in monitoring chicken flocks because 
antibodies can be detected early after infection and persist 
for several weeks. An advantage CF has over VN is that more 
sera can be tested more rapidly than by VN test. However, 
the CF antibodies may not have virus-neutralizing 
capability, since they appear very early after infection. 
f. Hemagglutination-inhibition. 
Although AIBV does .not cause direct 
hemagglutination (HA) of chicken erythrocytes, HA activity 
can be induced and the virus can be used in a 
hemagglutination-inhibition (HI) test (69,70). The HI is a 
simple, 
measuring 
possible. 
rapid, inexpensive, highly reproducible method of 
antibodies and individual serum testing is 
It can also be used for multistrain AIBV testing 
with specificity. It has been used as a virus-typing tool 
test is also valuable for monitoring the ( 71 ) • The HI 
immune status of chicken flocks and the efficacy of 
vaccination programs (42). However, the surface of the 
Virus must be modified in order to have HA activity and it 
has been noted that not all strains of AIBV exhibit this 
activity and not all strains are modified in the same way 
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(69). 
g. Enzyme-linked Immunosorbent Assay. 
Recently, immunoenzyme methods have been recognized 
as useful serologic tools for determining 
indices applicable to viral, bacterial, 
epidemiological 
and parasitic 
infections and for the detection of toxins in foods for 
human consumption (72). Among the most successful methods 
are those utilizing "labelled" antibodies and antigens. 
Enzyme labelled antibodies have been used for many 
years for the microscopic localization and identification of 
antigens in biological tissue sections (73). The first 
enzyme-immunoassay were described in 1971 independently by 
Van Weeman and Schuurs and by Engvall and Perlmann (74) who 
coined the name ELISA (enzyme linked immunosorbent assay). 
A few years later, the technique was adapted for microplate 
multiple assays by Voller (75). Since then more than a 
hundred papers have appeared on the subject attesting to its 
great promise (76). 
The ELISA has been shown to be a quantitative, 
rapid, reproducible, sensitive, specific, and simple 
test (77,78,79,80) for detecting antigen or antibody. The 
test depends on two assumptions: (i) that antigens and 
antibodies can be attached to a solid-phase support yet 
retain immunological activity and (ii) that either antigen 
or antibody can be linked to an enzyme and the complex 
retain both immunological and enzymatic activity (81). 
• 
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has shown that these assumptions are true for 
many antibody-antigen systems. 
The ELISA test was evolved due to an interest in 
developing a means of detecting infectious agents without 
relying on cultivation. With the ELISA, antigen can be 
detected and quantified using either a competitive ELISA 
system or a double antibody sandwich method. The 
competitive assay has a disadvantage in that each different 
antigen must be coupled to an enzyme. Due to the 
differences in antigenic structures, different coupling 
methods may be required. 
double antibody sandwich, 
The noncompetitive method, the 
for detection of antigen is the 
most useful because it only requires labelled antibody and 
the same procedure can be used for labelling all antibodies. 
The simplest noncompetitive system is the direct or 
one-antibody sandwich. One disadvantage of this single 
antibody approach is that it requires the laboratory to have 
different labelled antibodies for each antigen to be tested. 
This difficulty can be overcome by the use of the indirect 
ELISA which uses an enzyme-labelled anti-immunoglobulin. 
Since a single molecule of unlabelled antibody is able to 
react with a number of anti-globulin molecules, there is an 
increase in the number of enzyme molecules bound per 
molecule of antigen with a resulting increase in 
sensitivity. Consequently, the indirect ELISA is also more 
sensitive than its analogous direct system. 
19 
However, 
indirect system, 
there is one inherent disadvantage to the 
namely that reagents prepared in two 
different animal species must be used to prevent the non-
specific binding of the anti-immunoglobulin to the solid 
phase (82). 
There is also a great deal of interest in 
antibody levels, especially, in infectious measuring 
diseases. The indirect ELISA is the method of choice for 
the same reasons as expressed above. 
As with any type of immunoassay, the theoretical 
basis of the ELISA test is simple, but much work is needed 
to determine optimum specifications for a successful routine 
diagnostic test. In ELISA systems. there are countless 
possible permutations of variable such as the type of solid 
phase, the characteristics of the antigen/antibody coating 
on the solid phase, the test conditions, the type of enzyme 
and its conjugation to antibody or ~ntigen, 
of the enzyme substrate~ 
and properties 
There are some inherent dangers that the ELISA 
assay system may not be adequately standardized and 
controlled, 
therefore, 
with consequent misleading results. 
must be related to positive and 
All test, 
negative 
reference samples {81). Also, the methods for interpreting 
results of the ELISA are without definition and are, 
completely arbitary (72). The elimination of operators 
subjectivity in evaluating results and rationalization of 
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the assay design are obvious advantages which favor the 
ELISA, however, the inappropriate expression of data limits 
the usefulness of the ELISA (83). There should also be some 
standardization of the procedure so that between-run, 
between-laboratory, 
slight. 
and between-method variations are 
V. Treatment. 
There is no specific treatment for infectious 
bronchitis virus. In flocks of young chicks it is helpful 
to increase the temperature of the room as well as the 
brooder. Overcrowding should be avoided and drafts should 
be eliminated. Feed consumption in the flock should be 
encouraged to avoid excessive loss in weight in the birds. 
Recovery takes place as the birds acquire an immunity to the 
virus. 
VI. Prevention and Control. 
A. Management. 
Strict isolation of the flocK is the best 
prevention, along with sound management practices such as 
adding only day-old chicks as replacement stock and rearing 
them in isolation. However even with sound management 
practices, AIB may occur. This has brought on the necessity 
or using immunization programs in order to control the 
disease. 
B. Immunization. 
The immunization against AIBV has been reviewed by 
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Hofstad (84). 
The first immunization procedure used was started 
in 1941 in the New England states. It consisted of 
inoculating a small portion of the birds in a flock with a 
field isolate and allowing natural spread to the rest of the 
flock. This type of vaccination procedure using pathogenic 
field strains has been replaced with modified live virus 
vaccines. 
VII. Conclusion 
Although there is presently a wealth of information 
about AIBV, it is evident that much additional information 
is needed. 
Further investigation is required in the area of 
pathogenesis and epizootiology, the genetics, the chemical 
compost ion, as well as the physical properties and 
biological events of the virus-host cell relationship. 
The prime priority of investigators should be to 
establish the means by which new AIBV isolates can be 
recognized and categorized as to their serotype and their 
relationship to one another. 
MATERIALS AND METHODS 
Iirus_._ The Massachusetts 41 (M-41) strain of avian 
infectious bronchitis virus (AIBV), a coronavirus, was used 
throughout this study. The virus was obtained from Cecila 
Gulka, Department of Animal Pathology, University of Rhode 
Island. 
The virus was propagated in 9-to 11-day-old 
embryonated, specific-pathogen-free (SPF) (SPAFAS Inc., 
Norwich, Connecticut) or commercially obtained eggs. The 
procedure for virus propagation, as described by Rovozzo and 
Burke's (62), was as 
suspension containing 
follows: 
3.5 
10 ELD 
50 
0. 1 ml of the virus 
was inoculated into 
the chorioallantoic sac (CAS) or · each egg. Following 
inoculation, the eggs were incubated at 37°C and candled 
daily. Embryos found dead after 24 hours postinoculation 
(PI) were discarded as nonspecific deaths. After 36-48 hours 
PI, the eggs were chilled to 4 ° c before the allanto-amniotic 
fluids (AAF) were collected. The harvested fluid was pooled 
and clarified at 7,600 x g for 10 minutes (min) in a 
Sorvall RC-2B refrigerated centrifuge. Aliquots of the 
Virus suspension were then placed in stoppered tubes and 
kept at -20 ° c for later use. 
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The virus was titered in embryonated eggs by the 
method described by Rovozzo and Burke (62). The end point 
titer was determined by embryo lethal dose fifty percent 
(ELD ) and four eggs were used per dilution of virus. For 
50 
a detailed description of the method, see Appendix A. 
jirua ~oncentration, Purification, .a.n..s1. Isolation. Stock 
virus in AAF was concentrated on a 60% (w/v) sucrose 
cushion. Six ml of the 60% sucrose was carefully layed in a 
polyallomer centrifuge tube beneath 28 ml of the virus 
suspension. The virus suspension was centrifuged in a 
Sorvall OTD-50 ultracentrifuge using an AH-627 swinging 
bucket rotor for 1 1/2 hours at 83,100 x g. 
The visible band above the cushion was then 
collected and stored at -20°c. The virus suspension was 
further purified on a 20, 30, 50, and 60% (w/v) 
discontinuous sucrose density-gradient. One ml of virus 
suspension was layered on the top of the discontinuous 
gradient in cellulose centrifuge tubes. An AH-650 swinging 
bucket rotor was used in the OTD-50 ultracentrifuge and the 
virus was centrifuged for 3 1/2 hours at 153,000 x g. 
Using a Auto Densi-Flow (Haake Buchler Instruments, 
Inc., Saddlebrook, N. J. ) , ten fractions were collected 
from each centrifuge tube from different centrifugation 
runs. All fractions collected were checked for their density 
using a Bausch & Lomb ABBE-3L refractometer. These 
fractions were then used to check optimal centrifugation 
24 
times and to determine the specific density of the virus. 
In the determination of specific density of the 
virus, each of the ten fractions were serially diluted and 
the ELD 
50 
was determine. The density and their 
corresponding infectivity titers were then plotted. 
In subsequent centrifugation runs, the visible 
bands were collected, their densities determined, before 
being stored at -20°c. 
y1rus neutralization. The Beta procedure using a variable 
amount of serum and a constant amount of virus was employed. 
The chicken serum was diluted in two-fold serial 
concentrations with phosphate buffered saline (PBS) 
solution. A suspension containing 100 ELD of the virus in 
50 
0.1 ml was prepared. Using aseptic technique, the virus 
suspension was added to the serum dilutions in equal 
amounts. The mixture was then incubated at 37°C for 1/2 
hour. For each dilution, 0.2 ml of serum-virus mixture was 
inoculated into 4, 10-day-old embryonated egg. The eggs 
were observed daily and embryos that died after 24 hours PI 
were discarded. All other eggs were incubated for 6 days 
when they were opened and checked for signs of infection. 
A.ntisera oroduction. Rabbit anti-AIBV was prepared in a New 
Zealand white rabbit. A blood sample was taken from the 
rabbit prior to inoculation. Then 1.0 ml of a virus 
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suspension 
5 
containing 10 ELD /ml (density of 
50 
1 • 1 7 g/ml) 
was mixed thoroughly with 1.0 ml of Freund's complete 
adjuvant until an emulusion was formed •. The rabbit was 
inoculated intramuscularly with 0.5 ml of the virus-
adjuvant mixture into each hind leg. Following a two week 
period, the rabbit was inoculated intravenously in the right 
marginal ear vein with 1.0 ml of purified virus containing 
5 
10 virus particles. After another two week period, a 
small amount of blood was taken for testing purposes, and 
the rabbit was reinoculated intramuscularly with 0.5 ml of 
the virus in each hind leg. The rabbit was bled from 
alternating ears on day 7, 16, 25, 34, 42, and 50 after the 
final inoculation. The serum was collected. 
The blood taken was allowed to clot at room 
temperature. The tube was then rimmed with a wooden 
applicator stick and placed at 4°C overnight. The following 
day, the tube was centrifuged at 400 x g for 10 min. The 
serum was then carefully collected from the top of the tube, 
labelled, and stored at -20°C. 
The final serum sample was then tested by virus 
neutralization in eggs. The final serum preparation had a 
neutralization index of 640. The same serum sample was also 
tested in a modified indirect enzyme-linked immunosorbent 
assay (ELISA). The ELISA titer was 131,072. 
Immunoelectron microscopy. Electron microscopy was used to 
26 
verify the presence of virus at various stages in the study. 
Three hundred-mesh copper grids (Ted Pella Co. ) were 
cleaned in acetone overnight and then allowed to air dry. 
some grids were then coated with a formvar or a 
nitrocellulose film. Equal amounts of virus suspension and 
antisera were mixed together and incubated for 30 min at 
37° c to allow aggregates to form. Three different methods 
for negative staining were used. In the first method, 0.025 
ml of the virus-antibody mixture was dropped onto a sheet of 
parafilm. A coated grid was then placed on top of the drop 
for five minutes with the coated side facing down. The grid 
was then washed three times in distilled water before 
staining. A 2% phosphotungstic acid (PTA) solution at 
pH 7.1 was used to stain the grids for 15 seconds. In the 
second method, the coated grid was placed on a block of 2% 
Noble agar and a drop of the virus-antibody mixture was 
placed on top of the grid and allowed to absorb through the 
coating into the agar. The grid was then stained as above. 
In the final procedure, a pseudoreplication method was used. 
The virus was placed on a block of 2% Noble agar and allowed 
to diffuse for 20 min. Then a drop of nitrocellulose was 
Placed on top of the block and allowed to air dry for 20 
min. The film was then floated off at a 45 degree angle 
into a dish Of PTA. After 1 min, clean grids were placed 
onto the film and the film was lifted out of the stain by 
Using a small test tube. The stained grids were then viewed 
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using a Hitachi HS-9 electron microcope operating at an 
accelerating voltage of 75 Kvolts. (See Appendix B). 
~hickens. Two groups of White Leghorn chickens were used. 
In the early study, chickens raised from commercial eggs 
were used. In the latter study, chickens raised form SPF 
eggs were used. All chickens used were hatched and raised 
in isolation. 
Experimental Plans; 
Experiment no. 1. When the commercial chicks were one week 
of age, they were banded and identified with wing bands. At 
two weeks of age; blood was taken from the brachial veins, a 
throat swab was taken from the trachea, and a fecal swab was 
taken from the cloaca of each chick. After three weeks, 
the chickens in the infected group were inoculated 
4 
intratracheally with 0.1 ml of AIBV containing 10 ELD of 
50 
virus. At 1 , 3, 5, 7, 14, 21, and 28 days PI, blood for 
serum samples, throat swabs, and fecal swabs were taken from 
five chickens in each group. At 1, 2, 3, and 4 weeks PI two 
chickens were bled by heart puncture. The chickens were 
then sacrificed and their necks were broken, and their lungs 
were removed aseptically. 
Experiment no. 2 This experiment was similar to the first 
one with some slight modifications. SPF chicks were used, 
28 
and at 1, 2, 3, and 4 weeks PI the chickens were bled. At 
tbe end of week 4, 
intraocularly with 10 
the chickens were reinoculated (RI) 
4 
ELD of AIBV M-41. 
50 
Then at 1, 7, 
and 14 days RI, throat and fecal swabs were taken again and 
at 1 and 2 weeks PI, the chickens were bled for serum 
samples. 
~ample collection. Sterile swabs were used to collect 
throat and fecal swabs. Hank's balanced salts solution 
(HBSS) containing 1% fetal bovine serum, and 0.5% PSF 
(10,000 U/ml penicillin, 10,000 mcg/ml streptomycin, and 100 
mcg/ml fungizone) was prepared. In the first experiment, 
3.0 ml of HBSS was placed in sterile glass tubes. The swabs 
were wetted with HBSS and inserted into the trachea or the 
cloaca of the chicken. The swabs were swirled in the HBSS 
in the tubes. The swabs were then removed with forceps and 
the excess moisture removed by pressing the swab against the 
side of the tube. 
190 x g for 10 min. 
-20°c. 
The tubes were then centrifuged at 
The samples were labelled and stored at 
The second experiment was similar to the first, 
except 1.5 ml of HBSS was used and the tubes were 
centrifuged at 180 x g for 10 min. 
The lung tissue that was taken from the chickens 
were washed once in PBS and then placed in a small beaker of 
PBS. The tissue was minced with a pair of ~terile scissors. 
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The fluid was collected in a tube and centrifuged at 260 x g 
for 10 min to remove any red blood cells. The supernatant 
was collected in a sterile tube, labelled, and stored at 
-20 ° c for future use. 
The blood collected was prepared for sera the same 
way as described in the antisera production section, except 
that it was centrifuged at 260 x g for 15 min, due to the 
smaller amount of blood collected and the use of small 
tubes. 
Jirus isolation. Samples of tracheal and cloacal swabs from 
the control and infected group were thawed at room tempera-
ture and treated at the ratio 1:4 with the PSF to control 
contamination. One-tenth of a ml of the sample was then 
inoculated into each of four 10-day-old embryonated 
commercially obtained eggs. The eggs were candled daily 
and embryos that died after 24 hours PI were discarded and 
considered to be nonspeciric deaths. After 36 to 48 hours, 
one of the eggs in the set was refrigerated at 4° C overnight 
and harvested for used in a blind passage. After the sixth 
day PI, the remaining eggs were placed at 4° c overnight. 
The following day, the eggs were opened and examined for any 
signs of infection such as dwarfing of the embryo. If no 
infection was apparent, two additional blind passages were 
made in a similar fashion as described above. 
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.f.rotein Determination. A micro protein determination kit 
(Sigma Chemical, Co,, St. Louis, MO.) was utilized in order 
to determine the protein (mcg/ml) of various virus and 
antibody 
tryptophan 
samples. This assay system is dependant on 
and tyrosine content of proteins. A Baush 
the 
and 
Lomb Spectronic 21 spectrophotometer transmitting at 725 nm 
was used. The test sample were diluted with a 0.85% sodium 
chloride solution. To a tube labeled "blank" 0.4 ml of 0.85% 
sodium chloride solution was added. To the tubes labelled 
"test" 0.4 ml of the diluted test sample was added. To all 
tubes 4.4 ml of biuret reagent was added and the tubes were 
mixed well and allow to stand at room temperature for ten 
minutes. Next, 0.2 ml of Falin and Ciocalteu's Phenol 
reagent was added and mixed well immediately after addition. 
The tubes were allowed to stand at room temperature for 
thirty minutes. The contents of the tubes were transfered 
to cuvettes and the absorbance was read at the same 
wavelength and on the same instrument used to prepare a 
calibration curve using the blank as reference. 
The calibration curve was prepared using a protein 
standard diluted with 0.85% sodium chloride solution. The 
absorbance values versus protein concentration was then 
Plotted and the data was extrapolated in order to determine 
the amount of protein in the test sample used as a standard 
(See Appendix C). 
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iJ.ISA ,reagents. 
~reparation. AIBV was inoculated into SPF 
embryonated eggs. 
4°c overnight. 
After 36 hours, the eggs were chilled at 
The AAF was then harvested, pooled, and 
clarified in a RC-2B centrifuge at 7,650 x g for 10 min. The 
supernatant was harvested and centrifuged for 1 1/2 hours at 
76,600 x g in an ultracentrifuge. The pellet was harvested 
and resuspended in PBS. A protein determination was done 
and various dilutions of the virus suspension were tested in 
an ELISA test in order to optimize the antigen sensitivity. 
Antisera. Chicken anti-AIBV was obtained from a 
commercial source (SPAFAS Inc., N.orwich, CN. ) • This 
antiserum was used in the modified indirect double antibody 
sandwich (MIDAS) ELISA as the primary antibody. It was also 
used in the modified indirect (MI) ELISA as a positive 
control. 
The rabbit anti-AIBV serum that was prepared was used 
in the MIDAS ELISA as the secondary antibody. 
konjugate. Rabbit anti-chicken IgG (Heavy & Light chains) 
and goat anti-rabbit IgG (Heavy & Light chains) conjugated 
to horseradish peroxidase (HRP) were obtained from Cappel 
Laboratories, Inc. (Cochranville, PA.). 
The substrate-indicator solution was made by 
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dissolving 20 mg of orthophenylenediamine (OPDA) in 50 ml of 
phosphate-citrate buffer (pH 5). (See Appendix D ) • 
Immediately before using the substrate solution, 0.020 ml 
of a ~ 25°C. 30P hydrogen peroxide solution was added at 
~ .§.Qlution. The stopping solution used to stop the color 
reaction in the test was a two molar solution of sulfuric 
acid. 
~ntrols. The substrate control consists of substrate-
indicator solution and stopping solution. 
The conjugate control consists of conjugated 
antisera, substrate-indicator solution, and stopping 
solution. 
The antibody control in the MIDAS ELISA consists 
of the rabbit antiserum, conjugate, substrate, and stopping 
solution. 
The positive control antibody in the MI ELISA 
consists of SPAFAS anti-AIBV. The negative control antibody 
consists of SPAFAS negative serum or serum taken from one-
day old SPF chicks. 
The positive control antigen in the MIDAS ELISA 
consists of concentrated and three times purified AIBV. The 
negative control antigen consists of AAF prepared in the 
same manner as the control antigen. 
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!,.LISA lU'ocedures. 
M.Q.9ifie..d. indirect dQuble antibQdy sandwich m..e...t..h.2.Q. .f..2..r. 
.antigen getection. The ELISA assay was performed in 96 
flat bottom well, polystyrene Immulon 1 microtiter ELISA 
plates (Dynatech Laboratories, South Windham, ME.). The 
procedure is as follows: 
1. All wells were coated with 0,05 ml of a 
1:1,000 dilution of chicken anti-AIBV in 0.1 M carbonate-
bicarbonate buffer, pH 9.6 (Appendix D). The plates were 
covered with aluminum foil and incubated for 1 1/2 - 2 hours 
at 37°c. After incubation, the plates were washed three 
times (3X) with PBS-Tween 20 (0.08% [v/v]) using a 
Dynatech Miniwasher. 
2. Antigen dilutions were made 
96 well U-shaped microtiter plates (Bellco 
Vineland, N. J.). Fifty microliters of 
dilutions was added to each appropriate well. 
in 
Glass, 
the 
Costar 
Inc., 
antigen 
3. The first 9 wells of the horizontal row was 
used for the antigen negative control. The second 9 wells 
of the row was used for the known positive control antigen. 
The next rows were used for the negative control throat swab 
and negative control fecal swab followed by the test throat 
and fecal swabs and/or a negative control lung and a test 
lung sample. Of the 3 remaining horizontal wells, one 
vertical row was used for an antibody control, one for a 
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conjugate control, and the final row for a substrate 
control. 
4. The plates were covered and the antigen was 
0 incubated for 1 1/2 to 2 hours at 37 C. After incubation, 
the plates were washed 3X with PBS-T. 
5. Rabbit anti-AIBV M41 was diluted 1:2,000 with 
PBS-T. Fifty microliters was added to all the wells except 
the conjugated and substrate well which received PBS-T. The 
plates were covered and incubated for 1/2 hour at 37°c. 
After incubation, the plates were washed 3X with PBS-T. 
goat 
the 
were 
6. Fifty microliters of a 1:2,000 dilution of the 
anti-rabbit IgG was then added to all the wells except 
substrate well which received only PBS-T. The plates 
covered and incubated for 1/2 hour at 37°c. After 
incubation, the plates were washed 3X with PBS-T, followed 
by a final rinse with PBS. 
7. Hydrogen peroxide was added to the substrate 
indicator solution (see Appendix D) in subdued light. Fifty 
microliters was added to all the wells on the plate. After 
a predetermined reference point was reached, the reaction 
was stopped, and all the samples were read on a Dynatech 
MicroELISA Minireader MR 590 at 492 nm. The results were 
recorded (see Appendix E). 
M.Q.si..ii:ll.d, ind ire c t .m.e..t...lliU1 !Ju:_ .a D t i bod y d e t e c t i o n • Th e 
Procedure is as follows: 
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1. All the wells were coated with 0.05 ml of a 
1 : 100 dilution of AIBV antigen in 0.1 M carbonate-
bicarbonate buffer, pH 9.6. The plates were covered with 
plastic sealing tape to make a tight seal. 
then refrigerated, at 4 ° C overnight. 
The plates were 
2. The plates were allowed to warm up to room 
temperature. Then they were washed three times (3X) with 
PBS-Tween 20 (0.08% [v/v]) using a Dynatech Miniwasher. 
3. Two-fold dilution of the serum samples were 
made in Costar 96 U-bottom well microtiter plates using PBS-
Tween 20 (PBS-T) as the diluent. Fifty microliters of each 
dilutions was placed in its perspective well. 
4. The plate was set up a~ follows. The first 9 
wells in a horizontal row was used for a known positive 
control. The second 9 wells was used for a known negative 
(SPAFAS) control serum. The next 6 horizontal rows 
contained the samples to be tested. The three remaining 
wells in the horizontal rows were used for conjugate and 
substrate controls. 
5. The plates were then covered with aluminum 
foil and incubated for one hours at 37° C. 
the plates were washed 3X with PBS-T. 
After incubation, 
6. Peroxidase conjugated rabbit anti-chicken IgG 
was diluted 1:2,000 with PBS-T. Fifty microliters was then 
added to each well except the substrate control wells. The 
Plates were covered and incubated for 1/2 hour at 37 ° C. 
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After incubation, the plates were washed 3X with PBS-T, 
followed by a final wash with PBS. 
7. Hydrogen peroxide was added to the substrate-
indicator solution in subdued light. Fifty microliters was 
added to all the wells on the plate. After a predetermined 
reference point, the reaction was stopped. The plates were 
then read on the minireader. The results were recorded (see 
Appendix F). 
Qptimization a.rul. standardi.z.a.J<..i..2..n..._ All reagents used in the 
ELISAs were tested for optimal dilution factors and optimal 
incubation times in order to standardize the tests. 
Qa.t.a. interpretation. All positive samples were compared 
with the negative samples after taking the substrate, 
conjugate, and antibody absorbance values into 
consideration. The absorbance values usually range from 
0.00-1.99 and a difference of 0.20 between the negative and 
positive samples was considered significant. 
Reproducj~..1J...i.t..Y Q~ ~ results. Test sampies were run in 
duplicate and certain samples were run over a period of time 
in order to determine the reproducibility of the ELISAs. 
Statiiti~ analy~. A one-tailed Students' t test was 
used to analyze the data (see Appendix G). 
RESULTS 
IJ.rua ~oncentration, ourification, .a..w1. isolation. The virus 
suspension was layered on a discontinuous sucrose density-
gradient and centrifuged at 153,000 x g for 3 1/2 hours. 
Ten fractions ranging in densities of 1.07 to 1.27 g/ml were 
5.5 
collected. Peak infectivity (10 ELD ) correlated with 
50 
fraction five, which contained a visible band at a density 
of 1.17 g/ml. Virus was also detectable at densities 
between 1.13 and 1.23 g/ml. (Fig 1.) 
Standardization 52.L .tJ:ut modified indirect double antibody 
sandwich (MIDAS) ELISA. 
Standar~ MIDAS ELISA. No other investigators have reported 
on the use of MIDAS ELISA to detect AIBV. Therefore, 
conditions used for a standard MIDAS ELISA were determined 
on the basis of its similarity to the modified indirect 
ELISA. The primary antibody and antigen were both incubated 
for two hours at 37 °c. The secondary antibody and conjugate 
were both incubated at 37 ° C for thirty minutes. 
Standardization ~ ~ grimary antibody ~oncentration. 
Various dilutions of a chicken anti-AIBV were used to coat 
the microplates. Due to a low non-specific binding and 
37 
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high specificity, a chicken anti-AIBV dilution of 1:1,000 
containing 51 mcg/ml of protein was chosen. (Fig 2.) This 
dilution of antibody had a modified indirect ELISA titer of 
1/4096. 
standardization ~ ~ secondary .anti.bQil ~~.tration. 
various dilutions of a rabbit anti-AIBV were used in the 
standard MIDAS ELISA with a chicken antibody dilution of 
1:1,000. (Fig 3.) Due to the availability of a large amount 
of antibody, a dilution of 1:2,000 was chosen. This 
dilution contained 124 mcg/ml of protein and had an modified 
indirect ELISA titer of 1/131,072. 
Standardization ~ ~ conjugate concentration. Various 
dilutions of goat anti-rabbit IgG conjugated with HRP was 
used in the standard MIDAS ELISA. A dilution of 1:2,000 
containing 61 mcg/ml of protein was chosen due to a miminal 
amount of non-specific binding. (Fig 4.) 
Standardization ~ antibody .lU.nDing ~. A 1:1,000 
dilution of chicken anti-AIBV was used to coat several 
microplates which were then incubated at various time 
intervals. A positive and negative reference antigen were 
then added to the plates and the standard MIDAS ELISA plan 
was followed. One and one-half hours was chosen due to non-
specific binding and sufficient sensitivity. (Fig 5.) 
Soula and Moreau (85) demonstrated that the optimal 
binding time of antibody to antigen occured in a minimum of 
thirty minutes, this time was chosen and appeared suitable 
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for the incubation of the rabbit anti-AIBV. 
.s.,tandardizatiQil Qr All!Y antigen binding ..t..i.m.e.. Postive and 
negative reference antigen was incubated at various times in 
the standard MIDAS ELISA. An incubation time of one and one 
half hours was chosen due to low non-specific binding and 
sensitivity in detection of antigen. (Fig 6.) 
£ffec~ QI_ ~ .Qll ~..b..tl conjugate concentration. Using the 
standard MIDAS ELISA, the effect of time on the sensitvity 
of the conjugate at a dilution of 1:2,000 was tested. 
Fig 7. shows an increase in sensitivity as time progresses. 
An incubation time of thirty minutes was sensitive, had low 
non-specific binding, and was chosen in the interest of 
time. 
Substra.t...e_ incubation ..t..i.m.e.. Since it is difficult to achieve 
constant times and temperatures in all the conditions of the 
MIDAS ELISA, the subtrate reaction time was controlled by 
the inclusion of a reference antigen on each plate. When 
the reading of the reference sample reached a predetermined 
point, the reaction was stopped. 
Reprod~~hility 
4 
antigen (10 
results. A positive reference 
ELD ) was retested over a period of a 
50 
month. 
Comparable results with no significant variablitiy were 
obtained. 
Standardization .Q.!. .tJljt modified indirect .ilil.l ELISA. The MI 
ELISA for AIBV antibodies has been performed by several 
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investigators (68,78,79,86,87,88,89,90,91). Optimal antigen 
t d t b h t 37 oc binding time was repor e o e one our a or 
overnight at 4°C (85,90). Optimal antibody binding time was 
found to be a minimum of thirty minutes (85). One hour has 
been used previously in our laboratory ( 9 0). Significant 
binding of conjugate occurs within thirty minutes (92). 
Therefore, these parameters were used in a standard MI 
ELISA. Although most of the parameters have been optimized, 
standardization of the antigen and conjugate concentrations 
was necessary. 
Standardiza..LI.Qn QJ: antigen concentration. A checkerboard 
titration (93) was performed with different dilutions of the 
positive and negative reference sera 4sing the standard MI 
ELISA. A 1:100 antigen dilution containing 7.6 mcg/ml of 
protein was chosen. (Fig 8.) According to Clark and Adams 
(73), optimum coating of wells occurs with a protein 
concentration between 1 - 10 mcg/ml. The 1:100 dilution of 
AIBV gave maximum binding of antisera and showed the best 
comparison between high sensitivity and low non-specific 
binding. 
StandardizatjQn SU: ~~njugat~ ~oncentration. A checkerboard 
titration of the conjugate with positive and negative 
reference sera was run using the standard MI ELISA. A 
working dilution of 1:2,000 was chosen for the test due to 
an interest in economy. This dilution had a minimum amount 
Of non-specific binding but high sensitivity. (Fig 9.) 
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.ss.andardizallQ.n reference serum The 
titration 
depicted 
of a known positive and negative antisera is 
in Fig 10. The endpoint titer was 1:4092 for the 
known positive serum and less than 1:32 for the known 
negative serum. It was concluded that the specific dilution 
employed for the titration of the positive and negative 
reference sera would be enough to cover the complete range 
of the negative and positive end points expected in the test 
samples. 
Substrate incubation ~. The substrate incubation time 
was determined in the same manner as the MIDAS ELISA, except 
a reference antibody was used instead of the antigen. 
ReproguQibility 2.f. results. Repeated titrations of selected 
sera over a period of one month showed no significant 
variability in the end point titers. 
Experiment _t. Fifteen chickens comprised the control group 
and twenty-one chickens comprised the infected group. 
Chickens exhibited respiratory Clinical Q~~rvations. 
signs of AIBV (1,7). Signs commenced on the third day 
postinfection and continued until the seventh day. No signs 
were evident from the fourteenth day onward. The control 
chickens showed no signs of infection throughout the study • 
.f.Q.il.=Jn.Ql:.ifil!l examination. Chickens sacrificed and examined, 
showed cloudy air sacs; congested and hemorrhagic tracheas, 
With adherent mucous exudate; and congested and discolored 
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lungs. 
yir\lA i~olation. Table 1 shows virus isolation at different 
days postinfection and at various passages in embryonated 
chicken eggs. The virus was detected in 80% of the tracheal 
swabs tested at day one, in 100% of the swabs tested at 
three and seven days, and in 20% of the swabs at day 
fourteen. No virus was detected in the control swabs. 
The virus was detected in the feces of 40% of the 
swabs tested after one and seven days, 60% at three days, 
and 20% after day fourteen. Note that chicken no. 35 was 
late in showing signs of the virus and also persisted longer 
in shedding of the Virus. 
Mm ELISA. Table 2 shows the results of the detection of 
viral antigen in the trachea and fecal swabs of the infected 
chickens. 
isolation. 
These results were comparable with those of virus 
No virus was detected after twenty one days 
postinfection. The lungs from various chickens sacrificed 
throughout the study demonstrated the presence of virus from 
day three to day seven. 
after seven days. 
No virus was detected in the lung 
JU ~.L.llA.. 
Table 3. 
The immune response of the chickens is shown in 
A rise in titer was detected after seven days and 
continued to increase up to twenty-one days. In three out 
Of five chickens, there was a continued rise in titer up to 
the end of the study, while one of the remaining chickens 
decreased in titer and the other remained the same. 
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i.Jperimen~ ~. Twenty chickens comprised the control group 
and twenty chickens comprised the infected group. 
~incai ~.i..8..ru?.· Chickens exhibited signs of respiratory 
distress of AIBV infection (1,7). Signs commenced after the 
second day postinfection and continued until the fourteenth 
day. No signs were evident from the twentieth day onward. 
control chickens showed no signs of infection throughout the 
study. 
Post-mortem examination. Post-mortem examination of the 
sacrified chickens revealed similar signs as decribed in 
Experiment 1. 
Three chickens died after one week and two 
chickens died after two weeks. Tqe chickens appeared 
dehydrated and emaciated. 
!.irlui isolation. Table 4. shows that six out of six of the 
chickens infected contained virus in their throat swabs from 
day one to day fourteen. 
fourteen. 
In the fecal swabs, 
No virus was detected after day 
virus was detected up to day 
fourteen in four out of the six infected chickens. 
was detected after day fourteen. 
No virus 
No virus was isolated from the control chickens. 
MIDAS ELISA. Table 5 shows the presence of virus in 83%, 
100%, 33%, and 17% of the tracheal swabs after one, three to 
fourteen , twenty-one, and twenty-eight days post-infection 
respectively. These test results included only six infected 
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chickens. The chickens were reinfected after twenty-eight 
days, but, no virus was recovered. 
In the fecal swabs, virus was recovered in 67% of 
the samples from day one to seven, in 83% after day 
fourteen, in 33% on day twenty-one, twenty-eight, and one 
day after reinfection. No virus was recovered at day seven 
after reinfection. 
The lungs from various chickens sacrificed 
throughout the study demonstrated the presence of virus from 
day three to day fourteen. No virus was detected in the 
lungs after day fourteen • 
.Ml. ELISA. Table 6 shows a rise in antibody titer after 
seven 
days, 
days, reaching a maximum 
and declining after reinfection. 
titer at twenty-one 
After twenty-eight 
days, five out of eleven chickens showed a decline in titer, 
two of the remaining chickens showed a rise in titer, and 
the remaining four chickens remained the same. After 
reinfection: at seven days, two out of eleven chickens 
chickens declined in antibody titer, one rose, and eight 
remained at the same titer; at fourteen days, seven out of 
eleven chickens declined, two rose, and two remained at the 
same titer • 
.C.Umulatiye 
cumulative 
and by 
results. Table 7. and 
results of virus isolation 
MIDAS ELISA respectively. 
Table 8. show the 
in chicken embryos 
All controls were 
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negative, while throat and fecal swabs of the infected 
chickens demonstrated the presence of virus. It appears 
that isolation of virus by chicken embryos or MIDAS ELISA 
were comparable. 
Table 9. shows an increase in the mean log titers 
2 
of antibody after day seven in both Experiments 1 and 2. In 
Experiment 1 , there was a peak antibody titer after 
fourteen days and the mean titers remained high until the 
end of the study. After day three, the mean titers showed a 
significant (p = 0.02) difference between the control and 
infected groups. In Experiment 2, there was a peak antibody 
titer at day fourteen followed by a slow decline in titer. 
All the results were statistically sig~ificant (p = 0.001 ). 
Fig 11. illustrates the antibody response of the 
control and infected groups in both experiments 
graphically. 
Figure 1. Virus concentration, purificati o n, and 
isolation. Determination of the density 
(g/ml) [0] of avian infectious bronchitis 
virus. A suspension of AIBV in AAF was 
layered on a discontinuous sucrose density-
gradient and centrifuged at 153,000 x g for 3 
1/2 hours. Infectivity was determined in 
10-day-old chicken embryos. 
embryo-lethal dose/ml [ • ] • 
ELD = median 
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Figure 2. Standardization of the primary chicken anti-
AIBV (CAIBV) used in the MIDAS ELISA. The 
primary antibody was diluted in serial 
dilution and each dilution coated a two rows 
of wells in a microtiter plate for 2 hours 
at 37°c. A negative [ •] and positive [ 0] 
reference antigen was then serially diluted, 
added to the plates, and incubated for 2 
hours at 37°C. The secondary rabbit antibody 
and conjugate were added at a dilution of 
1:2,000 aqd incubated fo~ 1/2 hour at 
37°C. Substrate was added and the absorbance 
values recorded. A chicken anti-AIBV 
dilution of 1:1,000 was chosen for the test. 
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ruure 3. Standardization of the secondary rabbit anti-
AIBV (RAIBV). Plates were coated with 
1:1,000 dilution of the chicken anti-AIBV and 
then the positive [ 0] and negative 
reference antigen was added. Incubation for 
0 both steps was 2 hours at 37 C. A conjugate 
dilution of 1:2,000 was used. Incubation of 
the rabbit anti-AIBV and the conjugate was 
1/2 hour at 37 °C. Substrate was added and 
absorbance values recorded. A 1 :2,000 
dilution of rabbit anti-AIBV was chosen. 
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Figure 4. Standardization of goat anti-rabbit IgG-HRP 
(GAR IgG-HRP) conjugate concentration. The 
conjugate was serially diluted. The plates 
were coated with a 1:1,000 dilution of 
chicken anti-AIBV; a positive (OJ and 
negative [ •] reference antigen was then 
added, the incubation time for both steps 
was 2 hours at 37°C. Rabbit anti-AIBV at a 
1:2,000 dilution was added. 
antibody 
incubated 
and the 
for 1/2 
conjugate 
hour at 37 ° C. 
The rabbit 
were both 
Substrate 
was added and the results were recorded. A 
working diluton of 1:2,000 was chosen. 
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Figure 5 • Effects of incubation time on the primary 
chicken antibody (CAIBV). A 1:1,000 dilution 
of chicken anti-AIBV was used. The plates 
were incubated at various times before the 
addition of the antigen. A positive [ 0] and 
negative [ •] reference antigen was incubated 
for 2 hours at 37 ° C, while the rabbit 
antibody and goat anti-rabbit IgG conjugated 
with HRP (1:2,000) were incubated for 1/2 
hour at 37 ° C. Substrate was added and the 
absorbance values recorded. 
hours was chosen. 
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Figure 6. Time dependency of AIBV antigen attachment. 
Reference positive [ D] and negative [ •] 
antigen was added to antibody coated plates 
and incubated for various time periods. 
Rabbit anti-AIBV and conjugate were added at 
a dilution of 1:2,000 and incubated for 1/2 
hour at 37°C. Susbtrate was added and the 
absorbance values read. An incubation time 
of 1 1/2 hours was chosen for the test. 
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Figure 7. Time dependency of conjugate (GAR IgG-HRP) 
binding. A conjugate dilution of 1:2,000 was 
incubated for various times. The plates were 
coated with 1:1,000 dilution of chicken 
antibody. Reference positive [ ~ ] and 
negative [A] antigen was then added and the 
incubation time for both steps was 2 hours at 
37°C. Rabbit antibody at a dilution of 
1 :2,000 
37 ° C. 
was incubated for 1/2 hours at 
Substrate was added and the absorbance 
values recorded. There was sufficient and 
low non-specific binding of conjugate after 
30 minutes. 
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Figure 8 • Standardization of partially purified AIBV. 
Two rows on each plates were coated with a 
dilution of 1:50 [0], 1:100 [.6.], 1:200 [VJ, 
and 1:400 [ <) ]of AIBV antigen and incubated 
overnight at 4 ° c. Two-fold serially diluted 
positive and negative refer~nce sera were 
added and incubated for 1 hour at 37 ° C. 
Conjugate used at 1:2,000 was incubated for 
1/2 0 hour at 37 c. Substrate was added and 
the absorbance values read at 492 nm. The 
difference between the absorbance values of 
the positive and negative sera is shown. An 
antigen dilution of 1:100 was chosen. 
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Figure 9 • Standardization of rabbit anti-chicken IgG-
HRP (RAC IgG-HRP) conjugate concentration. 
AIBV antigen was used at a 1:100 dilution and 
incubated overnight at 4°C. A positive [ ~] 
and negative [A] reference c~icken anti-AIBV 
serum was incubated for hour at 37°C. 
Conjugate incubation time was 1/2 hour at 
37 °C. Substrate was added and the absorbance 
values read. 
was plotted. 
was chosen. 
A chicken serum dilution of 1:8 
A working dilution of 1:2,000 
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Figure 10. Standardization of a reference chicken anti-
AIBV (CAIBV} serum dilution. A known 
positive[~] and negative [A] reference 
sera were serially diluted two-fold. A 
1:100 antigen dilution coated the plates 
overnight at 4 ° C. The sera was incubated for 
1 hour at 37 ° C. A conjugate working dilution 
of 1 :2,000 was used and incubated for 1/2 
hour at 37 °c. Substrate · was added and 
absorbance values recorded. 
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Table 1. 
a 
Isolation 
(AIBV) in 
chickensb,c 
(Experiment 
of avian infectious bronchitis virus 
the throat and feces of infected 
by means of embryonated chicken eggs. 
1. ) 
Days postinfection 
j_ 
.ruu. .3. .li.Y§. 1~ 11i ~ 
d 
Bird no • f 1 f 2 f 3 f 1 f 2 f 3 f 1 f 2 f 3 f 1 f 2 f 3 
.csrntrQ l:i 
e g 
10 T 0 0 0 0 0 0 0 0 0 0 0 0 
9 T 0 0 0 0 0 0 0 0 0 0 0 0 
f 
10 F 0 0 0 0 0 0 0 0 0 0 0 0 
9 F 0 0 0 0 0 0 0 0 0 0 0 0 
Ic.!~~t~Q. 
e h i 
31 T + NT NT + NT NT + NT NT 0 0 0 
32 T + NT NT + NT NT + NT NT 0 0 0 
33 T + NT NT + NT NT 0 + NT 0 0 0 
34 T + NT NT + NT NT + NT NT 0 0 0 
35 T 0 0 0 + NT NT + NT NT 0 0 + 
f 
31 F 0 0 0 0 0 0 0 0 0 0 0 0 
32 F 0 + NT 0 + NT . o 0 0 0 0 0 
33 F 0 0 0 0 0 0 0 0 0 0 0 0 
34 F 0 + NT 0 + NT + NT NT 0 0 0 
35 F 0 0 0 0 + NT + NT NT 0 0 + 
a. Isolation Of virus was carried OU t in 10-day-old 
embryonated chicken eggs 
b. Chickens were three-weeks of age 
c. Chicken~ were infected by intra tracheal inoculation 
with 1 O ELD50/ml Of AIBV 
d. [ p] 
= Isolation of virus - no. of serial passage in 
embryonated eggs. 
e. [T] 
= Tracheal swabs r. [F] 
= Fecal swabs g. [ 0] 
= Negative virus isolation h. [+] 
= Positive virus isolation i. [NT]: Not tested 
Table 2. 
Bird no. 
~..r..Q.il 
c 
6 T 
7 T 
8 T 
9 T 
10 T 
d 
6 F 
7 F 
8 F 
9 F 
10 F 
Int:~Qt~!:l 
c 
31 T 
32 T 
33 T 
34 T 
35 T 
d 
31 F 
32 F 
33 F 
34 F 
35 F 
Detection of AIBV antigen from 
feces of infected chickens a, b 
modified indirect double antibody 
ELISA. (Experiment 1.) 
Days oostinfection 
1 3 5 7 14 
e f 
NT NT 
NT 
NT 
NT 
NT NT 
NT 
NT 
NT 
g 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+ + + 
+ + + + 
+ + + + 
a. Ch}ckens were infected by intra tracheal 
10 ELD5olml of AIBV 
b. Chickens were three-weeks Of age 
c. [T] = Tracheal swabs 
d. [F] 
= Fecal swabs 
e. [-] 
= Negative detection of antigen 
r. [+] = Positive detection of antigen 
g. [NT]= Not tested 
67 
the throat and 
by means of a 
sandwich (MIDAS) 
21 28 
NT 
NT 
NT 
NT 
inoculation with 
I 
I 
68 
a b,c 
Table 3. Antibody response in chickens following AIBV infection. (Experiment 1 ) 
IlaY~ 12o~tinfgQt,ion 
d 
Bird no. p 1 3 5 7 14 21 28 
~nti::Q.l 
e 
1 4 4 4 4 
2 1 6 1 6 1 6 1 6 
I 3 4 4 8 8 
4 8 8 8 1 6 
·1 5 4 4 4 4 
6 8 8 8 8 
I 7 8 8 8 4 
8 4 4 4 4 
9 8 8 8 16 
10 4 4 4 1 6 
Infected 
16 2 4 128 
17 4 4 64 
18 1 6 16 256 
19 4 4 
20 4 4 32 
21 8 8 32 
22 16 16 128 
23 8 32 256 
24 32 32 256 
25 8 8 64 
26 32 32 1024 
27 4 4 32 
28 16 1 6 32 
29 1 6 1 6 32 
30 32 32 256 
31 4 64 512 1024 1024 
32 8 128 1024 1024 2048 
33 4 128 512 512 256 
34 4 64 128 128 512 
35 2 1 6 64 64 512 
a. Antibody was detected by the modified indirect enzyme-
linked immunosorbent assay 
b. Chickens were infected by intratracheal inoculation with 
c. 
10 3 ELDsolml of AIBV 
Chickens were three-weeks of age 
d. [P] = Pre-infection serum 
e. Antibody titer expressed as the reciprocal of serum 
dilution 
Table 4. 
Bird no. 
~ontcol 
e 
10 T 
9 T 
6 T 
5 T 
f 
10 F 
9 F 
Int:~i.::t~d 
e 
25 T 
26 T 
27 T 
29 T 
33 T 
35 T 
f 
25 F 
26 F 
27 F 
29 F 
33 F 
35 F 
a 
Isolation of AIBV in the throat and 
infected chickensb, c by means of 
chicken eggs. (Experiment 2.) 
Days postinfection 
.1 ilY 1. llll ll llll 
d 
f J f 2 f 3 fl f 2 f 3 f 1 f 2 f 3 
Bicd~ 
g 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 
Bicd~ 
h i 
+ NT NT + NT NT + NT NT 
+ NT NT + NT NT 0 + NT 
+ NT NT + NT NT 0 + NT 
+ NT NT + NT NT 0 + NT 
+ NT NT + NT NT + + NT 
+ NT NT 0 + NT 0 + NT 
+ + NT + + NT + + NT 
0 0 0 0 0 0 0 0 0 
0 + NT + + NT 0 + NT 
+ + NT + + NT 0 + NT 
0 0 0 0 0 0 0 0 0 
0 + NT 0 + NT 0 0 + 
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feces of 
embryonated 
£.1 s1..ali. 
f 1 ,e, f 3 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
~ NT NT 
a. Isolation Of virus was carried out in 10-day-old 
embryonated eggs 
b. Chickens were three-weeks Of age 
c. Ch~ckens were infected by intra tracheal inoculation with 
d. 
10 ELDsolml 
[P] = Isolation of virus - no. of serial passage in 
[T] embryonated 
eggs 
e. 
= Tracheal swabs f. [F] 
= Fecal swabs g. [OJ 
= Negative virus isolation h. [+] 
= Positive virus isolation i. [NT]: Not tested j. [ D] 
= Death of chicken during testing 
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Table 5. Detection of AIBV antigen from the throat and feces of infected chickensa,b by means of a 
modified indirect double antibody sandwich (MIDAS) 
ELISA. (Experiment 2. ) 
DaIS Qost;!.nt:~QtiQn 
c 
Bird no. 3 5 1 1 4 21 28 29 35 
~ontrQl~ 
d f g 
5 T NT NT 
6 T NT NT 
7 T NT NT 
9 T 
10 T 
e 
5 F NT NT 
6 F NT NT 
7 F NT NT I 
1! 9 F 
10 F 
ID(~Qt~d. 
d h 
25 T + + + + + + 
26 T + + + + 
27 T + + + + + 
29 T + + + + + 
33 T + + + + + 
34 T NT NT NT NT NT + + 
35 T + + + + + Di D D D 
e 
25 F + + + + + 
26 F + 
27 F + + + + + + + + 
29 F + + + + + + + + 
33 F 
34 F NT NT NT NT NT + 
35 F + + + + + D D D D 
a. Chickens were infected by intra tracheal inoculation with 
1 0 3 ELD SO /ml 
b. Chickens were three-weeks of age 
c. Reinfection of chickens after t!enty-eight days 
postinfection intraocularly with 10 ELD 50 /ml of AIBV d. [T) 
= Tracheal swabs 
e. [F) 
= Fecal swabs r. [-] 
= Negative detection of antigen g. [NT): Not tested h. [ + J 
= Positive detection Of antigen i. [ D) 
= Death of chicken 
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Table 6. 
a 
Antibody 
infection • 
b, c 
response in chickens 
(Experiment 2.) 
following AIBV 
.Qa.1~ '2Q~t1Df:~Qt;i.Qll 
d e 
Bird no. p 1 14 21 28 35 49 
~ntr2l 
f 
3 2 2 2 2 2 4 4 
5 2 4 4 8 8 8 8 
6 2 2 4 4 4 4 4 
1 2 2 4 4 4 4 4 
8 2 2 2 2 4 2 2 
9 2 4 4 8 8 8 8 
10 2 2 2 4 4 4 4 
Int:~i::t~g 
22 
23 
24 
25 
26 
27 
29 
31 
33 
34 
35 
41 
a. 
b. 
c. 
d. 
e. 
r. 
g. 
f 
4 32 2048 2048 1024 1024 512 
4 1 6 2048 1024 512 512 512 
4 64 512 512 1024 1024 512 
8 1 6 1024 2048 1024 512 256 
8 32 1024 1024 1024 512 256 
4 64 2048 1024 1024 1024 512 
8 64 512 512 1024 1024 2048 
8 32 2048 1024 512 512 512 
8 256 2048 2048 1024 1024 2048 
2 64 64 64 64 64 512 
16 512 1024 Dg 
2 32 2048 512 512 1024 512 
Antibody was detected by the modified indirect enzyme-
linked immunosorbent assay 
Chjckens were infected by intratracheal inoculation with 
10 ELDsolml of AIBV 
Chickens were three-weeks of age 
[P] = Pre-infection serum 
Reinfection of the chickens aft3r twenty-eight days 
postinfection intraocularly with 10 ELD 5 0 /ml of AIBV 
Antibody titer expressed as the reciprocal of serum 
dilution 
[D] = Death of chicken 
/ 1 
r 
I 
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a 
Table 7. Isolation of AIBV in the throat and feces of 
embryonated 
of Experiment 
infected chickens b,c by means of 
chicken eggs. Cumulative results 
1 and Experiment 2. 
1 
Control group 
d f 
T 0/2 
Fe 0/2 
Infected group 
T 
F 
4/5 
2/5 
Control group 
T 
F 
0/4 
0/2 
Infected group 
T 
F 
616 
4/6 
3 
0/2 
012 
5/5 
3/5 
NT 
NT 
NT 
NT 
Days postinfection 
7 
0/2 
0/2 
5/5 
2/5 
0/4 
0/2 
6/6 
4/6 
14 
0/2 
0/2 
1/5 
1 /5 
0/4 
0/2 
6/6 
4 /6 
a. Isolation of virus was carried out in 10-day-old 
embryonated chicken eggs 
Chickens were three-weeks of age 
21 
g 
NT 
NT 
NT 
NT 
0/4 
012 
0/6 
0/5 
b. 
c. 
d. 
Chickens were infected by intratracheal inoculation 
with 10 3 ELD5olml of AIBV 
[T] = Tracheal swabs 
e. 
r. 
g. 
[F] = Fecal swabs 
number of positive isolations/ number of total tested 
[NT]= Not tested 
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Table 8. Detection of AIBV antigen from the throat and 
feces of infected chickens a ,b by means of a MIDAS 
ELISA. Cumulative results from Experiment 1 
and Experiment 2. 
Days postinfection 
1 3 5 7 14 21 28 
~~.1 
Control group 
c e 
T d 0/4 0/4 0/4 0/4 0/4 0/4 0/4 
F 0/4 0/4 0/4 0/4 0/4 0/4 0/4 
Infected group 
T 4/5 5/5 5/5 5/5 1/5 0/5 0/5 
F 2/5 3/5 3/5 2/5 1/5 0/5 0/5 
~ ~ .£ 
Control group 
T 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
F 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
Infected group 
T 5/6 6/6 6 /6 6/6 6/6 2/6 1/6 
F 4/6 4/6 4/6 4/6 5/6 2/6 2/6 
a. Ch~ckens were infected by intra tracheal inoculation with 
b. 
10 ELDso/ml of AIBV 
Chickens were three-weeks of age 
c. [T] 
= Tracheal swabs d. [F] 
= Fecal swabs 
e. number of positive detections I number Of total tested 
7 4 
a 
Table 9. Comparison of antibody response in noninfected 
and AIBV infected chickensb, c from Experiment 1 and 
Experiment 2. 
BeQiQ:ros;:al mean anti!2Qdy titer log 2 * SE iN.l d 
.ll.aY~ f I Euie:riment 1. ~.ruu:..i.m..e..n.t. _g_ 
e g 
0 cf 2.6 :I: 0.40 ( 5 ) 1 • 0 :I: 0 ( 7) j 
I 2. 1 
* 
0.28 ( 1 0 ) 2.4 ± 0.23 (12)** 
h 
c 2.6 
* 
o.44 ( 5) NT 
I 3.2 :I: 0.42 ( 1 0 ) NT 
3 c 2.6 * 0.44 ( 5) i NT I 3.8 :I: 0.33 ( 1 0 ) * NT 
5 c 2.6 * o.44 ( 5) NT I 4.0 
* 
0.45 (5)* NT 
7 c 2.6 :I: o.4o ( 5) 1. 3 
* 
0.18 ( 7) 
I 5.6 
* 
0.38 (9)* 5.8 :I: o.43 (12)** 
14 c 2.6 :I: 0.40 ( 5) 1 • 6 :I: 0.20 ( 7) 
I 8.2 :I: 0.73 (5)* 10 :I: 0.43 ( 12) •• 
21 c 3.0 :t 0.45 ( 5) 2.0 :I: 0.25 ( 7) 
I 7.6 :I: 0.54 ( 1 0). 9.6 :I: 0.43 (11)** 
28 c 3.0 :I: 0.45 ( 5) 2.0 
* 
0.25 ( 7) 
I a.a :I: 0.12 (10)* 9.5 :I: 0.39 ( 11 ) •• 
a. Antibody was detected by the modified indirect enzyme-
linked immunosorbent assay 
b. Chickens were three-weeks of age 
c. Chickens were infected by intra tracheal inoculation 
with 10 3 ELD 50 /ml of AIBV 
d. [PI] = Postinfection 
e. [ c] = Noninfected control chickens 
f. [I] 
= Infected chickens g. mean titer :I: standard error (total number of chickens) 
h. [NT] 
= Not tested i. [ . ]
= p~ 0.02 j. [••] 
= p~ 0.001 
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Figure 11. Immune response to infection with AIBV. 
Comparison of mean log MI ELISA titers in 
2 
Experiment 1 of control c.hicks [ D] and 
3 
chicks infected [ •] intratracheally with 10 
ELD /ml of AIBV and in Experiment 2 of 
50 
control chicks [ 0] and chicks [ •] infected 
3 
intratracheally with 10 ELD /ml of AIBV. 
50 
Bars represent the standard error (SE). 
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DISCUSSION 
Concentration and purification of AIBV was carried 
out in a sucrose density gradient centrifugation. The peak 
infectivity of AIBV in the gradient was visible by a band at 
the density of 1.17 g/ml (Fig 1). This correlated with the 
findings of MacNaughton ~ .a.J....... (16). However, Collins~ 
.al.a.. (15) showed AIBV had five separate infectivity peaks at 
1.14, 1.16, 1.17, 1w19, and 1.21 g/ml respectively. In this 
study, though only one peak was shown at 1.17 g/ml (Fig 1), 
virus infectivity was present from densities between 1.13 to 
1.23 g/ml. 
Raggi (94) demonstrated the presence of a small 
infective viral agent (VIRA) which coexisted with AIBV but 
was distinct from it. VIRA had a density of 1.18-1.21 g/ml 
in cesium chloride. In the present study, no efforts were 
made to isolate the small infective viral agent (VIRA). 
Standardization of the MIDAS and MI ELISA methods 
resulted in two serological tests that can be used to detect 
antigen and antibody. However, there were several 
Obstacles to overcome before these methods were usable. 
The first problem encountered was with the use of 
the microtiter plates. The plastics used in microtiter 
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plates display a negative electric potential at their 
surface (zeta potential) which is modified by adsorption of 
protein, but, not eliminated. This residual electrostatic 
field at the solid-solution boundary gives rise to a diffuse 
double-layer of ions at the interface. This double layer 
of ions containing free antigen or antibody can be displaced 
by vigorous or prolonged washing (76). 
Polystyrene microplates are widely used as the 
plastic support in ELISA methods because they can be coated 
so easily and show reproducibility in results (80). Most 
proteins (ie. antibody and antigen) are absorbed to plastic 
surfaces as a result of hydrophobic interaction between non-
polar protein substance and the non-polar plastic matrix and 
are not covalently bound ( 7 6). Unlike antigen-antibody 
interactions, this adsorption process is nonspecific. 
However, this immunoadsorption process can cause a 
problem. Because of the physical attachment of protein, 
bleeding can occur cau~ing a loss of adsorbed proteins 
during washing and incubation. This results in the loss of 
sensitivity due to non-specific binding of enzyme-labelled 
components which contribute significantly to the total bound 
enzyme activity. During incubation of the immobolized 
antigen or antibody with enzyme-labelled antibody or 
antigen, direct adsorption of the conjugate onto the solid 
Plate can occur. This non-specific adsorption can be 
minimized by the inclusion of Tween-20, a neutral detergent 
79 
(76,77,80). This non-ionic detergent can be added in 
concentrations that prevent formation of new hydrophobic 
interaction between added protein and the solid phase. 
However, these detergents do not appreciably disrupt 
physical bonds already formed between previously adsorbed 
antigen or antibody and the plastic surface. 
HRP was chosen as the enzyme conjugate because of 
its unusual stability, high reactivity, and easy storage 
(77). Use of this enzyme conjugated to the heavy and light 
chain anti-immunoglobulins allows the conjugate to react 
with the major heavy and light chain immunoglobulin 
determinates of all classes. Piela (92) stated that use of 
the HRP conjugated 
immunoglobublin, in 
to the heavy and . light chain anti-
the ELISA, only measured IgG. The 
investigator used this assumption to explain the difference 
observed between the ELISA and the HI test. This assumption 
was incorrect. 
The substrate, OPDA, is colorless initially, but 
yields a colored product on degradation. OPDA is highly 
sensitive in the ELISA test, but, unfortunately, it is 
mutagenic and photosensitive (80). 
The amount of conjugate added to ~he system is 
chosen by trial and error in order to give a satisfactory 
sensitivity (74). Sensitivity can be increased by lengthen-
ing the duration of the enzyme-substrate indicator reaction 
Which results in the accumulation of the product with time. 
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A problem was encountered with the enzyme-substrate 
indicator system. Color development continued even after 
the addition of the stopping solution. This problem was 
reported before and could not be alleviated (77). This was 
one reason why the inclusion of positive and negative 
reference sera was important. Other reasons include changes 
in antigen or antigen concentration, dilution of antibody or 
conjugate or both which can effect the absorbance values. 
Inclusion of the reference samples help eliminate systematic 
components of error and gives analytical consistency to the 
absorbance value measurements (72,83). 
In the MIDAS ELISA, problems of non-specific 
binding were overcome during optimiza~ion procedures. The 
final testing system had low non-specific absorbance values. 
In the MI ELISA, the problems with non-specific 
binding of avian immunoglobulins as described by Slaught ~ 
.al.. (95) 
described 
and the presence of inhibitors in the serum as 
by Lukert (96) were generally not encountered. 
The addition of fetal calf serum to mask the polystrene 
surface (89,97) was therefore not necessary. 
Adsorption of AIBV onto the microtiter plate had 
the best result using a carbonate-bicarbonate buffer at an 
alkaline pH of 9.6. It was reported by Cunningham and 
Hofstad, that AIBV had maximum stability at pH 7.8 (1,7). 
However, Soula and Moreau (85) showed that the use of the 
carbonate-bicarbonate buffer at pH 9.6 had little effect on 
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the virus. The carbonate-bicarbonate buffer at pH 9.6 had 
no apparent effect on the virus in this study. 
The prozone effect as described by Bruins ~ .aJ...a. 
(97) was encountered at low serum dilutions at the begining 
of immunization. The early IgG antibodies were not able to 
resist washing procedures when crowded and also were not 
able to aligned on the antigen site at low serum dilutions. 
They did resist washing when they were not as crowded. 
During later immunization, the antibodies had a high 
affinity for the antigenic sites and were able to "hang-on" 
through washing even though crowded and poorly aligned. 
In both the MIDAS and MI ELISA methods, 
unexplainable irregularities on the plate or the "plate 
effect" (73,80) was not generally encountered in this study. 
In Experiments 1 and 2, the clinical and post-
mortem results were similar to those previously reported 
(1,7). 
In Experiment 1, virus was isolated from six out 
of six tracheal swabs of chickens for seven days. However, 
in Experiment 
tracheal swabs 
2 virus was isloated from six out of 
of chickens for fourteen days (Table 
six 
7 ) . 
This difference could be attributed to the use of commerical 
Chickens in Experiment compared to the use of SPF chickens 
in Experiment 2. 
In Experiment 1, the results of virus isolation by 
Chicken embryos and the MIDAS ELISA showed comparable 
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sensitivity. However, dwarfing and death of chick embryos 
was not always evident, and as is shown in Table 1 several 
passages of the virus in chicken embros may be necessary in 
order to isolate the virus in the test sample. The results 
of the MIDAS ELISA, on the other hand, does not need 
repeated passage of the test sample and can be 
the photometrically analyzed, which eliminates 
investigator's subjectivity. 
In Experiment 2, the results of virus isolation by 
chicken embryos and the detection of viral antigen by the 
MIDAS ELISA differed slightly. There was a reduction in the 
isolation of AIBV in chicken embryos. This could be due to 
the presence of maternal antibody in the commercial eggs 
used for virus isolation (42). Another explanation for 
this difference is the MIDAS ELISA can detect and measure 
antibodies directed against both infectious and non-
infectious viral antigens (87,89). In contrast, virus 
isolation in embryonated chicken eggs can only detect 
infectious viral antigens. 
Results of the detection of viral antigen by the 
MIDAS ELISA demonstated persistence of the viral antigen in 
the feces. This has also been reported to occur in a low 
Proportion of chickens in other flocks (46). Studies 
assessing the duration of AIBV infections in chickens 
(46,47) show that AIBV may enter organs of the respiratory 
tract from the blood stream due to viremia. The virus can 
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al SO be present in the small and large intestines in great 
Some quantity for a relatively long period of time. 
investigators feel that AIBV can aa,tually multiply in the 
intestines (46), although, this has not been proven to date. 
Regardless of this fact, AIBV can be detected in the feces 
of the chicken for extended periods of time and in the 
presence of humoral antibodies. How the virus accomplishes 
this feat is unknown. 
Persistence of infection of chickens with AIBV is 
an important factor for the poultry industry to consider. 
Non-infected chickens sharing the same house with 
persistently infected chickens can become infected (46,47). 
Reinfection can also occur if there is ,a sufficient decrease 
in the chicken's protective antibodies. Stress can also 
induce clinical disease in those chickens persistently 
infected with AIBV (46). 
The results of the detection _of humoral antibody in 
infected chickens by the MI ELISA were comparable with 
results shown by other investigators using similar MI ELISA 
techniques and serum neutralization tests (78,79,87,88). 
This study showed that there was a loss in the detection of 
AIBV in the infected chickens as the humoral antibody titer 
of the chickens increased. This was probably due to coating 
of viral antigens by immune sera causing destruction of the 
antigen by the avian immune system (12, 98). 
It has been suggested by several investigators that 
I , 
I' 
' L 
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virus isolation attempts should be done within ninety-six 
hours postinfection (99,100). Results in this study tend to 
agree with this recommendation. This time restriction 
should also apply to the MIDAS ELISA. 
The ELISA methods are an important means of 
detecting infectious agents and immune responses in animals. 
Even with the countless possible permutations of variables 
used in the ELISA methods, the ease of procedure, low cost 
of materials, reagent stability, short test time, safety, 
sensitivity, reproducibility, are many advantages of the 
ELISA methods (75,76,77,78,79,80,81,82,84,85,86,87,88,89,90, 
91,92,93,97). 
There is however a need for an ELISA that is 
uniform and can be applied universally. Presently, it is 
difficult to compare inter-laboratory results. Since there 
is no standard ELISA plan, intra-laboratory results can only 
be compared by use of a positive and negativw reference 
serum or antigen. The value of the MIDAS ELISA for 
detecting antigen and the value of the MI ELISA for 
detecting antibodies can only be ascertained if all 
laboratories pool their resorces together to create a 
universal system. 
2. 
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APPENDIX A 
Determination of embryo lethal dose fifty percent in 
embryonated chickens eggs. 
Dilutions of Virus Spanning the 
]00 i tQ 0 i At:t:~Qteg Hang~ 
a b c 
10 10 1 0 
d 
Infective (death) rate 4/4 2/4 0/4 
Number affected 4 2 0 
Number surviving 0 2 4 
Accumulate the affected 
(Total starting at most = 4 + = 2 + 
dilute level; accumulate 
most concentrate level) 6 2 0 
Accumulate unaffected 
(Total starting at most 
concentrate level; = 2 + = 4 + 
accumulate towards most 
dilute level) 0 2 6 
Express the mortality rate 
(No. affected/total) 6/6 2/4 0/6 
Express % mortality 100 % 50 % 
a = most concentrated dilution that shows 100 % affected 
b = the next dilutions between "a" and "b" 
c = most dilute level that shows 0 % affected 
0 % 
d = the number of embryos affected/total per dilution tested 
To compute the acutal end point dilution use the following 
formula: 
oer Qent mQrtality next abQve 50 % - 50 % 
Per cent mortality next Per cent mortality next 
above 50 % below 50 % 
= proportionate distance. 
Find the log of that dilution in which per cent mortality is 
next about 50 %. Multiply the proportionate distance X log 
of the dilution factor 10 to obtain the real value of the 
Proportionate distance (round to the nearest tenth). 
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APPENDIX B 
Plate I. AIBV from infected AAF of 10-day-old embryonated 
chicken eggs was harvested after 30 hours PI and 
clarified at 7,650 x g for 10 minutes. The virus 
was then stained using pseudoreplication. The 
stained grids were viewed with a Hitachi HS-9 EM 
at 75 Kv. The corona are indicted by an arrow. 
(Mag 269,000 X) 
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Plate II. The ELISA antigen-antibody complex. AIBV 
from infected AAF of 10-day-old embryonated 
SPF eggs was harvested after 36 hours PI and 
clarified at 7,650 x g for 10 min. The virus 
suspension was then pelleted at 76,700 x g 
for 1 1/2 hours. The pellet was resuspended 
in PBS. Chicken anti-AIBV was added to the 
virus suspension and incubated for 30 min at 
37o ·c. The virus-antibody mixture was then 
stained using the agar block method. The 
stained grid was view with a Hitachi HS-9 EM 
at 75 Kv. Corona are indicated by arrows. 
(Mag 286,000 X) 
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APPENDIX C 
Determination of protein concentrations of various 
ELISA test reagent was carried out. In Fig. 12, protein 
concentration vs absorbance (725 nm) was plotted to obtain a 
calibration curve. Various test samples' absorbance values 
were then extrapolated and their protein concentrations 
determined. 
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y1gure 12. Protein 
antibody 
• 
concentrations 
samples were 
Of antigen and 
plotted on a 
calibration curve which used bovine albumin 
as a protein standard. The known protein 
concentrations (x) were read at an 
absorbance value of 725 nm and plotted. The 
test samples: chicken anti-AIBV (CAIBV)[Q ], 
rabbit anti-chicken IgG conjugated to HRP 
(RAC-HRP) [e], rabbit anti-AIBV (RAIBV)(DJ, 
goat anti-rabbit IgG conjugated to HRP (GAR-
HRP) [ • ] , ELISA antigen (ELISA Ag) [ !:::. ] , and 
purified AIBV ( P-IBV) [ .& ] ; . absorbance values 
were read and extrapolated on the calibration 
curve to determine the protein concentration 
(mcg/ml). 
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APPENDIX D 
Chemical formulations of reagents used in the ELISA test. 
PHOSPHATE BUFFERED SALINE (PBS) 
.f..atl A: 
NaCl 
KCl. 
40 g 
1. 0 g 
MgC12 6H20 •••••• 
CaC12 2H20 •• 
o.66 
0.50 
g 
g 
Distilled water •••••• 4000 ml 
1.a..I:...t. ]. : 
Na2HP04. 
KH2P04 • 
5.75 g 
1 • 0 g 
Distilled water •• 1000 l!Jl 
Mix Part B with Part A. 
CARBONATE-BICARBONATE BUFFER 
Add: 
Dilute: 
Adjust: 
Store: 
4.53 ml 
1.82 ml 
up to 100 
pH 9.6 
of 8.4 % sodium bicarbonate solution 
of 10.6 % sodium carbonate solution 
ml with distilled water 
at 25°C not more than two weeks 
[NaHC03 and Na(C03)2 at 4°C] 
SUBSTRATE INDICATOR SOLUTION 
Prepare: 
Add: 
Mix in: 
Store: 
Use: 
0~1M citric acid (1.92 g/100 ml) 
0.2M sodium phosphate dibasic (2.84 g/100 ml) 
24.3 ml of 0.1M citric acid 
25.7 ml of 0.2M sodium phosphate dibasic 
50.0 ml of distilled water 
40 m§ of orthopheneylenediamine at pH 5.0 
at 4 C in a foil covered container 
immediately before use added 0.040 ml of a 
30 % hydrogen peroxide solution at 25 ° c. 
1 0 1 
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APPENDIX E 
Diagramatic illustration of steps involved in the modified 
indirect double antibody sandwich (MIDAS) enzyme-linked 
immunosorbent assay (ELISA). 
I. 1° Ah steJ> 
[CAIB'J y 
2. Ag,... sa m P.le 
~IBVJ 
• 
0 
3. 2 Ab step 
[RA IBVJ 
A 
step 
4. Conjugate step 
[GAR lgG-HRf] 
A 
5. Suhstra le step [o PDA] 
* * 
* 
103 
104 
APPENDIX F 
Diagramatic illustration of the steps involved in the 
modified indirect (MI) enzyme-linked immunosorbent assay 
(ELISA)• 
MI ELI SA 
I. Ag step 
(AIBV) 
. t 
a Ah step 
(CAIBV) 
A 
3. Conjugate step 
(RAC lG -HRP) 
4. Substrate step 
(0 P DA) 
* * 
* 
10 5 
• 
APPENDIX G 
Statistical Methods and Formulas 
Mean: x = 1 /n L x 
where n is the number of observation in samples 
and x is the observed measurements 
Standard deviation: s = )1 /n-1 L ( x-x) 2 ; 
L(x-x) 2 = Lx2 - 1/n (Lx) 2 
Variance: s 2 
Standard error (SE): x ~ sl.y;:: 
Comparison of means of two small samples (unknown variances 
assumed to be equal): 
s 2 = + - 2 
t = 
s V 1/n 1 + 1/n 2 
use one-tailed Student's t-test to find the percentage 
point for the probability of observing a value of t 
Confidence limits: x ~ ts/y'll (P = 0.05) 
1 nfi 
ABBREVIATIONS 
AE = Avian encephalomyelitis 
AGP = agar gel precipitation 
AIB = Av~an infectious bronchitis 
AIBV = Avian infectious bronchitis virus 
C = control group of chickens 
CAIBV = chicken anti-avian infectious bronchitis virus 
CAM = chorioallanotic membrant 
CAS = chorioallantoic sac 
CEKC = chicken embryo kidney cells 
CF = compliment-fixation test 
ELD50 = median embryo lethal dose 
ELISA = enzyme-linked immunosorbent assay 
EM = electron microscope 
F = fecal swabs 
GAR IgG ~ goat anti-rabbit immunoglobulin G 
HI = hemagglutination inhibition 
HRP = horseradish peroxidase 
I = infected group of chickens 
IF = immunofluorescence 
ILT = infectious laryngotracheitis 
Kv = Kilovolts 
M-41 = Massachusetts strain of AIBV 
M-42 = Beaudette strain of AIBV 
M-46 = Connecticut strain of AIBV 
MI = Modified indirect 
MIDAS = Modified indirect double antibody sandwich 
NANA = N-acetylneuraminic acid 
NDV = Newcastle disease virus 
NT = not tested 
OPDA = orthophenylene diamine 
PBS = Phosphate buffer saline 
PI = postinfection 
PSF = penicillin, streptomycin, and fungizone 
PTA = phosphotungstic acid 
RAC IgG = rabbit anti-chicken immunoglobulin G 
RAIBV = rabbit anti-AIBV 
RI = reinoculation 
RNA = ribonucleic acid 
SPF = specific pathogen free 
T = tracheal swabs 
VI = virus isolation 
VN = virus neutralization 
v = volume 
w = weight 
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